Loading...

Article: Navigating Health Equity in 2024: The Evolution of Accountability, Part 1

2024-02-05T21:13:21+00:00Thought Leadership|

2024 will be the first full year in which health systems will be held accountable by The Joint Commission (TJC) for performance on their National Patient Safety Goal to improve health care equity. Marueen Hennessey, SVP, Director of Value Transformation, PRECISIONvalue with Elizabeth Oyekan, VP Pharmacy and Imaging Services, Stanford Health Care and Valerie Nguyen, Healthcare Administration Graduate Intern at Stanford Health Care share their unique perspectives in this AJMC article.

READ THE ARTICLE HERE!

Read More

Access90: Inflation Reduction Act Insight Series – Payer Controls: Two Key Questions Answered

2024-02-04T14:04:03+00:00News, Thought Leadership|

Patients already look beyond their prescription benefits for ways to pay. As cost-sharing rises and payer formulary controls and exclusions expand, patient demand for new solutions will grow. PRECISIONvalue Chief Medical Officer Dominic Galante discusses the future of access management in this Access90 video.

WATCH THE VIDEO HERE!

Read More

On Demand: Quantifying Health Equity Impact of Innovative Healthcare Interventions

2024-02-23T22:53:53+00:00Events, Thought Leadership|

The COVID-19 pandemic laid bare disparities in access to quality healthcare and resources that have led to poor outcomes among racial and ethnic minorities, socioeconomically vulnerable individuals, and populations in rural areas. With a renewed and keener scrutiny of health equity issues, the distributional consequences of a new intervention across subgroups should come to the forefront of discussions about value in health.

Join Precision HEOR for a webinar about studying the health equity impacts of new interventions. We will outline the conceptual basis of how health interventions can affect health equity and consider distributional cost-effectiveness analysis with decision-analytic models as a practical approach to assess this quantitatively. We will discuss the evidence needs and typical gaps for new interventions and how to optimize the use of existing data. The discussion will conclude with a live Q&A.

(more…)

Read More

Precision Medicine Group Releases Its Inaugural Environmental, Social and Governance (ESG) Report

2023-12-14T13:45:09+00:00Thought Leadership|

Precision is proud to have published our inaugural 2023 Environmental, Social and Governance (ESG) Report, reflecting the company’s ongoing efforts to do better for our people, in our practices, and with the broader community at large. This year’s report shares key achievements, performance metrics, and steps we have taken to enhance sustainability throughout the company, including:

· Engaging internal and external stakeholders in our company’s first ESG materiality assessment to identify and prioritize our material issues

· Defining Precision’s approach to ESG in our company’s ESG Strategy Statement · Creating a three-year strategic ESG Roadmap for advancing our performance across environmental, social, and governance issues · Initiating energy efficiency projects and standards across our facilities

· Implementing implicit bias training for our Executive Leadership Team and Human Resources leaders

· Contributing volunteer hours by over 425 employees and over $250,000 in donations to more than 70 charitable foundations and causes

Read the Full Report Here

Read More

Article: Anshul Mangal of Project Farma Discusses Policy Strategies to Address the Current Cancer Drug Shortage

2023-11-09T13:45:06+00:00Thought Leadership|

In September, the American Association for Cancer Research reported that hospitals are facing the worst chemotherapy drug shortage crisis the US has ever seen. Anshul Mangal, President of Project Farma, sat down with AJMC to address the primary reasons for the current cancer drug shortages and how Project Farma is helping to address these challenges.

READ THE ARTICLE HERE!

Read More
Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC. All Rights Reserved.